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Table  1  Clinical  characteristics  of  all  reports  of  malignant  hypertension  with  diffuse  alveolar  haemorrhage.
Case  Age  Gender  Nationality  Smoking  Previous  HT  Family  history  of  HT  Air  travel  Ref.
1  34  Male  Japanese  NR  1  month  NR  NR  1
2  26  Male  North  American  1--2  cig./day  No  Both  parents  Yes  5
3  26  Male  Japanese  NR  3  years  NR  Yes  3
4  38  Male  Canadian  9  packs-year  3  months  NR  NR  4
5  32  Male  Japanese  NR  5  years  Both  parents  NR  6
6  27  Male  Japanese  >30  pack-year  No  NR  NR  2
7  51  Male  Portuguese  >30  pack-year  No  Mother  No  --
HT: systemic hypertension; cig.: cigarette; NR: no reference; Ref.: reference.3
4
5However,  it  is  worth  noting  that  no  other  ﬁndings  have  sup-
ported  this  hypothesis,  and  this  may  be  just  a  non-signiﬁcant
association.  In  conclusion,  our  and  previous  reports  of  malig-
nant  hypertension  associated  DAH  suggest  that  high  blood
pressure  may  be  a  signiﬁcant  cause  of  alveolar  haemorr-
hage.  Clinicians  caring  for  DAH  patients  should  be  aware  of
this  association.  We  also  propose  large-scale  studies  on  the
association  between  systemic  blood  pressure  and  the  risk
of  alveolar  haemorrhage  which  could  open  the  way  to  new
treatment  of  DAH  with  BP  lowering  agent.
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Mesothelial cyst of the
pulmonary ligament: An
uncommon lesion
Dear  Editor,
The  importance  of  a  thorough  knowledge  of  thoracic
anatomy  is  timeless.  Lung  and  pleural  anatomy  continues  to
be  a  subject  for  study  nowadays,  not  only  due  to  the  greater
spatial  resolution  of  newer  diagnostic  studies,  such  as  bron-
choscopy,  computed  tomography  and  magnetic  resonance,
but  also  because  of  advances  in  thoracic  surgery.
The  pulmonary  ligaments  are  among  the  lesser  known
structures  of  the  thoracic  anatomy.  The  radiological  impor-
tance  of  the  pulmonary  ligament  was  ﬁrst  described  in
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966  by  Rabinowitz  and  Wolfe,1 and  only  very  few  reports
r  series  have  been  found  which  describe  the  radiologi-
al  ﬁndings  of  pathologic  processes  within  the  pulmonary
igaments.1--6 This  ligament,  just  like  any  other  thoracic
natomical  structure  can  be  affected  by  non-infectious  or
nfectious  inﬂammatory  processes,  tumors,  congenital  or
evelopmental  abnormalities  and  scarring.2--6 There  are  only
 few  reports  in  the  literature  which  mention  this  anatomical
tructure  and  different  pathological  process.
The  following  case  description  of  a  cystic  lesion  within
he  right  pulmonary  ligament  illustrates  the  anatomy  and
athology  of  this  structure:
A  75-year-old  woman  diagnosed  with  a  pharyngeal  can-
er  was  referred  for  magnetic  resonance  imaging  of  the
eck  and  a  computed  tomography  (CT)  of  the  chest  and
50  
Figure  1  CT  shows  a  cyst  within  the  pulmonary  ligament  sep-
arated  by  fat  plane  from  the  pericardium.
upper  abdomen.  The  enhanced  CT  chest  demonstrated
an  incidental  tubular  cystic  lesion,  oriented  parallel  to
the  mediastinum,  within  the  right  pulmonary  ligament,
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3. Cooper C, Moss AA, Buy JN, Stark DD. CT appearance of thextending  from  the  level  just  caudal  to  the  right  inferior  pul-
onary  vein  down  to  the  diaphragm.  This  lesion  measured
.5  cm  ×  2.7  cm  ×  1.8  cm  and  showed  homogeneous  density,
ean  attenuation  value  =  −3.92  Hounsﬁeld  Units  (HU).  This
esion  was  separated  from  pericardium  by  a  layer  of  fat.
he  lesion  was  followed  up  and  remained  stable  in  size  and
hape  for  4  years,  as  per  the  comparison  with  a  previous  CT
can.  The  appearance  on  axial,  coronal  and  sagittal  planes
onﬁrmed  that  the  cyst  was  within  the  pulmonary  ligament
Figs.  1  and  2).  The  cystic  lesion  also  had  no  depression  of  the
ilar  structures  or  elevation  or  blurring  of  the  diaphragm.
o  the  non-symptomatic  clinical  setting  alongside  with  the
natomical  landmarks  described  and  the  lack  of  change  in
ize/conﬁguration  during  these  years  supported  the  diagno-
is  of  a  mesothelial  cyst  of  the  pulmonary  ligament.
This  case  under  discussion  provides  a  very  good  illustra-
ion  of  the  anatomical  concepts  that  deﬁne  the  pulmonary
igament  as  double  layer  of  pleura  that  drapes  caudally  from
he  lung  root  and  ropes  the  medial  aspect  of  the  lower  lobes
f  the  lung  to  the  mediastinum.2 On  the  left,  the  ligament
s  medial  and  adjacent  to  the  esophagus  and  is  bounded
osteriorly  by  the  descending  aorta.  On  the  right,  the  lig-
ment  is  posterior  to  the  inferior  vena  cava  and  anterior  to
he  azygos  vein.2--4 Each  ligament  contains  connective  tis-
ue  which  blends  with  the  hilar  connective  tissue  superiorly,
nd  with  mediastinal  connective  tissue  medially.  Laterally,
he  connective  tissue  of  the  ligaments  is  continuous  with  the
nterstitial  connective  tissue  of  the  lung.2--4
On  CT  scans  normal  ligament  can  be  visible  as  a  thin  lin-
ar  density  arising  from  the  mediastinum  below  the  hilar
tructures  on  lung  window.3
Few  reports  in  the  literature  have  described  air  within
he  pulmonary  ligament,  post-traumatic  or  from  ruptured
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igure  2  CT  sagittal  view  shows  the  tubular  cystic  lesion  lat-
rally  to  the  inferior  vena  cava,  extending  from  the  level  of  the
ight inferior  pulmonary  vein  to  the  diaphragm.
neumatoceles  in  neonates  under  mechanical  ventilation.4--6
oreover,  around  11--18%  of  mediastinal  masses  are  related
o  the  foregut  developmental  abnormalities,  including  bron-
hogenic  or  duplication  cysts.  The  phase  of  the  embryonic
evelopment  during  which  the  error  occurs  seems  to  play
 role  in  the  location  and  type  of  malformation.  Foregut
ysts  arise  late  in  the  gestation.  The  age  of  presentation
ay  vary  from  prenatal  to  late  adulthood.  Almost  a  quarter
f  the  patients  with  foregut  cysts  are  asymptomatic.7 The
resented  clinical  case  therefore  illustrates  a  rare  but  typi-
al  cystic  lesion,  probable  arising  from  developmental  error
ithin  the  pulmonary  ligament.
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High-ﬂow nasal oxygen is not an
oxygen  therapy device
Traditionally  the  oxygen  therapy  systems  have  been  classi-
ﬁed  as  low  and  high  ﬂow.  Low-ﬂow  systems  do  not  provide
all  the  inspiratory  ﬂow  demanded  by  the  patient;  do  not
ensure  stable  levels  of  FiO2 and  it  is  not  possible  to  con-
trol  the  temperature  and  moisture  of  inspired  gas.  The  low
ﬂow  oxygen  system  most  widely  used  is  the  nasal  prongs.  By
contrast,  high  ﬂow  systems  are  able  to  provide  the  entire
atmosphere  breathed  by  the  patient  and  do  ensure  a  sta-
ble  FiO2 and  it  is  possible  to  control  the  temperature  and
moisture  of  the  inspired  gas.  The  typical  high  ﬂow  oxygen
system  is  the  venturi  mask.1 In  recent  years,  a  new  way  of
supplying  patients  with  oxygen  has  appeared  which  in  our
opinion  has  been  incorrectly  called  high-ﬂow  nasal  cannula
oxygen  therapy  (HFNC).2 This  therapeutic  approach  has  a
lot  of  physiological  effects  which  makes  it  a  really  active
treatment  for  patients  with  both  acute  and  chronic  respira-
tory  failure;  it  is  more  than  a  simple  oxygen  delivery  system.
Several  studies  have  shown  that  HFNC  generates  a  low  level
of  positive  airway  pressure,  improves  oxygenation,  increases
the  end-expiratory  lung  volume,  reduces  airway  resistance,
increases  functional  residual  capacity  and  alveolar  recruit-
ment  and  ﬂushes  nasopharyngeal  dead  space,  thus  helping
to  decrease  the  work  of  breathing.  There  is  a  better  control
of  FiO2 and  the  gas  humidiﬁcation  ensures  better  patient  tol-
erance  and  comfort.  Due  to  a  better  mucociliary  clearance,
pulmonary  defense  mechanisms  are  restored.3 Many  of  these
effects  are  similar  to  those  produced  by  non-invasive  venti-
lation.  Several  studies  have  shown  its  utility  in  patients  with
acute  hypoxemic  respiratory  failure,  in  the  post-extubation
period,  in  palliative  care,  in  patients  with  acute  heart  fail-
ure,  in  chronic  airway  diseases  and  its  indications  are  still
rising.  It  is  used  in  critical  care  areas,  in  the  emergency
department,  in  wards  and  it  is  being  used  at  home  in  COPD
patients.4,5
As  we  can  see,  oxygen  plays  a  secondary  role  in  this
treatment.  The  name  of  high-ﬂow  oxygen  therapy  is  con-
fusing.  Although  the  efﬁcacy  of  improvement  in  respiratory
high-ﬂow  therapy,  the  end  expiratory  positive  pressure,  the
ﬂushing  of  nasopharingeal  dead  space  or  the  humidiﬁcation
and  warming  of  the  inspired  air,  has  not  been  clariﬁed  yet.
Up  to  now,  we  have  not  been  able  to  identify  the  functional
signiﬁcance  of  each  of  the  three  mechanisms,  maybe  this
is  a  question  that  will  never  be  answered  because  in  dif-
ferent  clinical  situations  the  relevance  of  these  potencial
mechanisms  changes.  What  is  clear  is  that  high-ﬂow  is  not
an  oxygen  therapy  device.  Most  international  groups  work-
ing  in  this  ﬁeld  use  the  term  ‘‘Nasal  High  Flow’’  avoiding  the
term  ‘‘oxygen’’  in  its  deﬁnition.
We  think  such  an  active  treatment  should  have  a  name
that  reﬂects  the  effects  of  the  treatment  better,  in  order
to  avoid  confusion.  And  that  deserves  some  careful  reﬂec-
tion.  High-ﬂow  can  be  applied  through  nasal  cannula  or
tracheostomy,  so  the  term  ‘‘nasal’’  should  not  be  part  of
the  name.  Perhaps  the  name  ‘‘Active  High  Flow’’  would  be
more  accurate  so  as  to  clearly  distinguish  it  from  the  conven-
tional  or  ‘‘passive’’  high  ﬂow  like  the  venturi  system.  The
Venturi  system  is  usually  administered  by  mask  and  high  ﬂow
by  cannula,  which  could  be  another  distinguishing  feature.
Taking  into  account  the  different  but  also  relevant  effects
of  the  therapy,  we  might  ask  why  not  include  the  term
‘‘humidiﬁcation’’  or  ‘‘heating’’  to  the  words  ‘‘high  ﬂow’’.
The  positive  expiratory  pressure  effect  could  probably  be
more  interesting  to  incorporate  into  the  name.  Although
the  pressure  achieved  is  highly  dependent  on  the  individ-
ual  patient  and  the  interface  used,  is  low  in  absolute  value
and,  above  all,  not  determined  by  the  prescribed  param-
eters  of  the  equipment,  we  do  have  quite  a  lot  about  its
relevance.  Certainly,  this  therapy  has  demonstrated  that  can
be  useful  in  treating  sleep  apnea  syndrome.6,7 Its  effect  on
alveolar  recruitment  has  been  clearly  shown  by  Corley  et  al.8
Roca  et  al.9 have  also  indirectly  demonstrated  the  positive
intrathoracic  pressure  reached  with  the  HFNC,  showing  a
reduction  greater  than  20%  in  the  estimated  inspiratory  col-
lapse  of  the  inferior  vena  cava  from  baseline.  Perhaps  the
provocative  name  of  ‘‘High-ﬂow  positive  pressure’’  would
better  deﬁne  a  treatment  that  gives  the  patient  a  high  ﬂow
of  heated  and  wet  gas,  with  a level  of  positive  pressure,
and  a controlled  FiO . Anyway,  the  name  of  high-ﬂow  oxygengas  exchange  and  effectiveness  in  outcomes  has  been
demonstrated,  we  have  not  fully  understood  the  main
pathophysiological  principles  of  this  therapy.  The  role  and
importance  of  each  of  the  mechanisms  related  to  the
t
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herapy  would  be  restricted  to  the  classical  high  ﬂow  system
uch  as  the  venturi  system.  We  think  that  a  consensus  on  a
ore  precise  name  is  required.
